Thus, our results indicate that tumor cells sensitized by sirolimus become more dependent than normal cells on BCL2 and MCL1 for sustained survival, thus increasing their susceptibility to apoptosis in the absence of these key pro-survival proteins. This evidence concerns the gene BCL2 and neoplasm.